|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02393 YESTAR HEALTH
Nominal 
0.125 -0.008 (-6.015%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 802,634 | -36.988% | 2,409,916 | 2,912,733 | 4,293,982 | 4,930,692 |
| Cost of Sales | (668,897) | -36.666% | (2,010,714) | (2,399,951) | (3,585,273) | (4,081,997) |
| Gross Profit | 133,737 | -38.551% | 399,202 | 512,782 | 708,709 | 848,695 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 19,087 | 54.002% | (156,655) | 38,837 | (142,004) | (7,321) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | 1,083,407 | 24,705 | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 19,731 | 7,994 | |
| Profit / (Loss) before Taxation | 21,152 | -98.098% | 929,643 | 41,040 | (1,107,342) | 59,942 | |
| Taxation | (10,004) | -49.470% | (26,666) | (39,562) | 86,748 | (47,263) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | 536 | (2,749) | -- | -- | |
| Non-controlling Interests | (5,387) | 40.947% | 18,101 | (12,617) | 28,362 | (9,352) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 5,761 | -99.471% | 921,614 | (13,888) | (992,232) | 3,327 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 6,515 | -69.327% | 28,674 | 162,318 | 292,996 | 160,942 |
| Depreciation & Amortisation | 19,240 | -54.300% | 79,715 | 81,010 | 230,776 | 232,905 |
| Directors' Emoluments | -- | -- | 8,487 | 7,062 | 7,371 | 12,035 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified (Modified Report) | Disclaimer | Unqualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 0.250 | -99.465% | 39.530 | -0.600 | -42.600 | 0.100 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.005 | 0.165 | (0.039) | 0.305 |
| NBV per share ($) | 0.201 | -- | 0.198 | (0.196) | (0.175) | 0.324 |
| Remarks: | Real time quote last updated: 11/09/2025 17:29 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 5,761 |
| %Change | -99.471% |
| EPS / (LPS) | RMB 0.003 |
| NBV Per Share (¥) | RMB 0.201 |